Cargando…
Reproducibility of right-to-left shunt quantification using transthoracic contrast echocardiography in hereditary haemorrhagic telangiectasia
AIM: Transthoracic contrast echocardiography (TTCE) is recommended for screening of pulmonary arteriovenous malformations (PAVMs) in hereditary haemorrhagic telangiectasia. Shunt quantification is used to find treatable PAVMs. So far, there has been no study investigating the reproducibility of this...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bohn Stafleu van Loghum
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876176/ https://www.ncbi.nlm.nih.gov/pubmed/29497946 http://dx.doi.org/10.1007/s12471-018-1094-4 |
_version_ | 1783310463260426240 |
---|---|
author | Vorselaars, V. M. M. Velthuis, S. Huitema, M. P. Hosman, A. E. Westermann, C. J. J. Snijder, R. J. Mager, J. J. Post, M. C. |
author_facet | Vorselaars, V. M. M. Velthuis, S. Huitema, M. P. Hosman, A. E. Westermann, C. J. J. Snijder, R. J. Mager, J. J. Post, M. C. |
author_sort | Vorselaars, V. M. M. |
collection | PubMed |
description | AIM: Transthoracic contrast echocardiography (TTCE) is recommended for screening of pulmonary arteriovenous malformations (PAVMs) in hereditary haemorrhagic telangiectasia. Shunt quantification is used to find treatable PAVMs. So far, there has been no study investigating the reproducibility of this diagnostic test. Therefore, this study aimed to describe inter-observer and inter-injection variability of TTCE. METHODS: We conducted a prospective single centre study. We included all consecutive persons screened for presence of PAVMs in association with hereditary haemorrhagic telangiectasia in 2015. The videos of two contrast injections per patient were divided and reviewed by two cardiologists blinded for patient data. Pulmonary right-to-left shunts were graded using a three-grade scale. Inter-observer and inter-injection agreement was calculated with κ statistics for the presence and grade of pulmonary right-to-left shunts. RESULTS: We included 107 persons (accounting for 214 injections) (49.5% male, mean age 45.0 ± 16.6 years). A pulmonary right-to-left shunt was present in 136 (63.6%) and 131 (61.2%) injections for observer 1 and 2, respectively. Inter-injection agreement for the presence of pulmonary right-to-left shunts was 0.96 (95% confidence interval (CI) 0.9–1.0) and 0.98 (95% CI 0.94–1.00) for observer 1 and 2, respectively. Inter-injection agreement for pulmonary right-to-left shunt grade was 0.96 (95% CI 0.93–0.99) and 0.95 (95% CI 0.92–0.98) respectively. There was disagreement in right-to-left shunt grade between the contrast injections in 11 patients (10.3%). Inter-observer variability for presence and grade of the pulmonary right-to-left shunt was 0.95 (95% CI 0.91–0.99) and 0.97 (95% CI 0.95–0.99) respectively. CONCLUSION: TTCE has an excellent inter-injection and inter-observer agreement for both the presence and grade of pulmonary right-to-left shunts. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12471-018-1094-4) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5876176 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Bohn Stafleu van Loghum |
record_format | MEDLINE/PubMed |
spelling | pubmed-58761762018-03-30 Reproducibility of right-to-left shunt quantification using transthoracic contrast echocardiography in hereditary haemorrhagic telangiectasia Vorselaars, V. M. M. Velthuis, S. Huitema, M. P. Hosman, A. E. Westermann, C. J. J. Snijder, R. J. Mager, J. J. Post, M. C. Neth Heart J Original Article AIM: Transthoracic contrast echocardiography (TTCE) is recommended for screening of pulmonary arteriovenous malformations (PAVMs) in hereditary haemorrhagic telangiectasia. Shunt quantification is used to find treatable PAVMs. So far, there has been no study investigating the reproducibility of this diagnostic test. Therefore, this study aimed to describe inter-observer and inter-injection variability of TTCE. METHODS: We conducted a prospective single centre study. We included all consecutive persons screened for presence of PAVMs in association with hereditary haemorrhagic telangiectasia in 2015. The videos of two contrast injections per patient were divided and reviewed by two cardiologists blinded for patient data. Pulmonary right-to-left shunts were graded using a three-grade scale. Inter-observer and inter-injection agreement was calculated with κ statistics for the presence and grade of pulmonary right-to-left shunts. RESULTS: We included 107 persons (accounting for 214 injections) (49.5% male, mean age 45.0 ± 16.6 years). A pulmonary right-to-left shunt was present in 136 (63.6%) and 131 (61.2%) injections for observer 1 and 2, respectively. Inter-injection agreement for the presence of pulmonary right-to-left shunts was 0.96 (95% confidence interval (CI) 0.9–1.0) and 0.98 (95% CI 0.94–1.00) for observer 1 and 2, respectively. Inter-injection agreement for pulmonary right-to-left shunt grade was 0.96 (95% CI 0.93–0.99) and 0.95 (95% CI 0.92–0.98) respectively. There was disagreement in right-to-left shunt grade between the contrast injections in 11 patients (10.3%). Inter-observer variability for presence and grade of the pulmonary right-to-left shunt was 0.95 (95% CI 0.91–0.99) and 0.97 (95% CI 0.95–0.99) respectively. CONCLUSION: TTCE has an excellent inter-injection and inter-observer agreement for both the presence and grade of pulmonary right-to-left shunts. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12471-018-1094-4) contains supplementary material, which is available to authorized users. Bohn Stafleu van Loghum 2018-03-01 2018-04 /pmc/articles/PMC5876176/ /pubmed/29497946 http://dx.doi.org/10.1007/s12471-018-1094-4 Text en © The Author(s) 2018 https://creativecommons.org/licenses/by/4.0/Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Vorselaars, V. M. M. Velthuis, S. Huitema, M. P. Hosman, A. E. Westermann, C. J. J. Snijder, R. J. Mager, J. J. Post, M. C. Reproducibility of right-to-left shunt quantification using transthoracic contrast echocardiography in hereditary haemorrhagic telangiectasia |
title | Reproducibility of right-to-left shunt quantification using transthoracic contrast echocardiography in hereditary haemorrhagic telangiectasia |
title_full | Reproducibility of right-to-left shunt quantification using transthoracic contrast echocardiography in hereditary haemorrhagic telangiectasia |
title_fullStr | Reproducibility of right-to-left shunt quantification using transthoracic contrast echocardiography in hereditary haemorrhagic telangiectasia |
title_full_unstemmed | Reproducibility of right-to-left shunt quantification using transthoracic contrast echocardiography in hereditary haemorrhagic telangiectasia |
title_short | Reproducibility of right-to-left shunt quantification using transthoracic contrast echocardiography in hereditary haemorrhagic telangiectasia |
title_sort | reproducibility of right-to-left shunt quantification using transthoracic contrast echocardiography in hereditary haemorrhagic telangiectasia |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876176/ https://www.ncbi.nlm.nih.gov/pubmed/29497946 http://dx.doi.org/10.1007/s12471-018-1094-4 |
work_keys_str_mv | AT vorselaarsvmm reproducibilityofrighttoleftshuntquantificationusingtransthoraciccontrastechocardiographyinhereditaryhaemorrhagictelangiectasia AT velthuiss reproducibilityofrighttoleftshuntquantificationusingtransthoraciccontrastechocardiographyinhereditaryhaemorrhagictelangiectasia AT huitemamp reproducibilityofrighttoleftshuntquantificationusingtransthoraciccontrastechocardiographyinhereditaryhaemorrhagictelangiectasia AT hosmanae reproducibilityofrighttoleftshuntquantificationusingtransthoraciccontrastechocardiographyinhereditaryhaemorrhagictelangiectasia AT westermanncjj reproducibilityofrighttoleftshuntquantificationusingtransthoraciccontrastechocardiographyinhereditaryhaemorrhagictelangiectasia AT snijderrj reproducibilityofrighttoleftshuntquantificationusingtransthoraciccontrastechocardiographyinhereditaryhaemorrhagictelangiectasia AT magerjj reproducibilityofrighttoleftshuntquantificationusingtransthoraciccontrastechocardiographyinhereditaryhaemorrhagictelangiectasia AT postmc reproducibilityofrighttoleftshuntquantificationusingtransthoraciccontrastechocardiographyinhereditaryhaemorrhagictelangiectasia |